Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):273.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Arthritis / etiology
  • Arthritis / pathology
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Lupus Erythematosus, Systemic / chemically induced
  • Lupus Erythematosus, Systemic / etiology
  • Lupus Erythematosus, Systemic / pathology*
  • Mixed Connective Tissue Disease / complications
  • Mixed Connective Tissue Disease / drug therapy
  • Mixed Connective Tissue Disease / pathology*
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins / adverse effects*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Withholding Treatment

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Etanercept